image
Amneal Pharmaceuticals, Inc. AMRX
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
Watchlist
$ 8.47
-5.89 %
$ 3.91 B
Market Cap
-9.85
P/E
INCOME STATEMENT
2.39 B REVENUE
8.20%
Growth Rates
1Year 8.20%
3Years 6.30%
5Years 7.56%
7Years 12.99%
10Years 0.00%
204 M OPERATING INCOME
-1.01%
Growth Rates
1Year -1.01%
3Years 30.88%
5Years 65.43%
7Years -4.63%
10Years 0.00%
-48.7 M NET INCOME
80.88%
Growth Rates
1Year 80.88%
3Years -19.59%
5Years 24.70%
7Years -3.03%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Amneal Pharmaceuticals, Inc.
image
Revenue 2.39 B
Cost Of Revenue 1.57 B
Gross Profit 821 M
Operating Expenses 616 M
Operating Income 204 M
Other Expenses 253 M
Net Income -48.7 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 2 393.6 2 212.3 2 093.7 1 992.5 1 626.4 1 663.0 1 033.7 1 018.2 866.3 785.6
GROSS PROFIT
Cost Of Revenue 1 573.0 1 427.6 1 324.7 1 364.1 1 273.4 946.6 507.5 420.8 367.1 336.0
Gross Profit 820.6 784.7 769.0 628.4 353.0 716.4 526.2 597.5 499.2 449.6
OPERATING INCOME
Operating Expenses 616.2 595.8 575.1 517.3 491.9 440.9 301.0 323.5 277.8 239.6
Selling, General and Administrative Expenses 429.7 399.7 365.5 326.7 289.6 230.4 109.0 118.8 109.7 84.6
Research and Development Expenses 167.8 200.0 209.6 190.6 202.3 210.5 191.9 204.7 136.9 106.7
Operating Income 204.4 206.5 209.2 91.2 (137.4) (19.7) 245.1 284.9 227.2 222.9
PRE-TAX INCOME
Interest Income Expense 210.6 158.4 136.3 146.0 168.2 143.6 71.1 55.3 0 0
Total Other Income (244.6) (153.2) (121.3) (126.9) 28.4 (183.0) (73.8) (70.1) (60.6) (39.2)
Pre-Tax Income (40.3) (248.1) 31.4 (35.8) (220.2) (202.7) 171.3 214.8 175.6 179.3
NET INCOME
Tax Provision 8.5 6.7 11.2 (104.4) 383.3 (1.4) 2.0 5.4 5.0 1.5
Net Income (84.0) (254.8) 20.2 68.6 (603.6) (169.7) 167.6 207.4 169.5 176.9
EPS 0.48 1.69 0.14 0.47 4.57 1.33 1.46 1.81 0.9 0